Cetera Advisor Networks LLC Sorrento Therapeutics, Inc. Transaction History

Cetera Advisor Networks LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.74 - $1.83 $5,267 - $13,025	-7,118 Reduced 28.61%	17,762 $15,000
Q3 2022 Nov 10, 2022	BUY	$1.51 - $2.88 $3,661 - $6,984	2,425 Added 10.8%	24,880 $39,000
Q2 2022 Aug 11, 2022	BUY	$1.24 - $2.33 $4,712 - $8,854	3,800 Added 20.37%	22,455 $45,000
Q1 2022 May 12, 2022	BUY	$2.0 - $4.9 $2,000 - $4,900	1,000 Added 5.66%	18,655 $43,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $82,095 - $127,645	17,655 New	17,655 $82,000
Q3 2020 Nov 13, 2020	SELL	$6.17 - $18.82 $50,902 - $155,265	-8,250 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.73 - $6.76 $14,272 - $55,770	8,250 New	8,250 $52,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.